ID

22920

Description

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).; ODM derived from: https://clinicaltrials.gov/show/NCT00337779

Link

https://clinicaltrials.gov/show/NCT00337779

Keywords

Versions (1)
  1. 6/16/17 6/16/17 -
Uploaded on

June 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779

English

Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. diagnosis of confirmed and documented ms defined by the revised mcdonald criteria.
Description

Multiple Sclerosis

Data type

boolean

Alias
UMLS CUI [1]
C0026769
2. subjects must be of the relapsing-remitting (r-r) type.
Description

Multiple Sclerosis, Relapsing-Remitting

Data type

boolean

Alias
UMLS CUI [1]
C0751967
3. subject has experienced prior to screening at least one documented relapse in 12 months or at least 2 documented relapses in the 24 months or one documented relapse between 12 - 24 months with at least 1 documented t1-gd enhancing lesion in the mri performed 12 months prior screening.
Description

Relapse Quantity | Gadolinium-Enhancing Lesion Quantity Magnetic Resonance Imaging

Data type

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1333400
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0024485
4. disease duration for at least 6 months.
Description

disease length

Data type

boolean

Alias
UMLS CUI [1]
C0872146
5. ambulatory with converted kurtzke edss score of 0 - 5.
Description

Ambulatory Kurtzke multiple sclerosis rating scale

Data type

boolean

Alias
UMLS CUI [1,1]
C0439841
UMLS CUI [1,2]
C0451246
6. relapse free and stable neurological condition at least for 30 days prior screening.
Description

Condition Neurologic Stable | Relapse Free of

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0205494
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C0332296
7. age - 18-55 (inclusive)
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. previous use of copaxone (glatiramer acetate)
Description

Copaxone | glatiramer acetate

Data type

boolean

Alias
UMLS CUI [1]
C0528175
UMLS CUI [2]
C0289884
2. treatment with corticosteroids within 30 days prior screening or between screening and baseline.
Description

Adrenal Cortex Hormones

Data type

boolean

Alias
UMLS CUI [1]
C0001617
3. chronic corticosteroids treatment - more than 30 consecutive days.
Description

Adrenal Cortex Hormones chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0205191
4. subject with any clinically significant or unstable medical condition.
Description

Medical condition Clinical Significance | Medical condition Unstable

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2826293
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0443343
5. subjects participating in any other clinical trial (within 12 weeks prior to screening and thereafter).
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
6. known history of sensitivity to gadolinium and inability to successfully undergo mri scanning.
Description

Hypersensitivity Gadolinium | Magnetic Resonance Imaging Receive Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016911
UMLS CUI [2,1]
C0024485
UMLS CUI [2,2]
C1514756
UMLS CUI [2,3]
C1299582
Back to the top of the page

Similar models

Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis
Item
1. diagnosis of confirmed and documented ms defined by the revised mcdonald criteria.
boolean
C0026769 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
2. subjects must be of the relapsing-remitting (r-r) type.
boolean
C0751967 (UMLS CUI [1])
Relapse Quantity | Gadolinium-Enhancing Lesion Quantity Magnetic Resonance Imaging
Item
3. subject has experienced prior to screening at least one documented relapse in 12 months or at least 2 documented relapses in the 24 months or one documented relapse between 12 - 24 months with at least 1 documented t1-gd enhancing lesion in the mri performed 12 months prior screening.
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1333400 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0024485 (UMLS CUI [2,3])
disease length
Item
4. disease duration for at least 6 months.
boolean
C0872146 (UMLS CUI [1])
Ambulatory Kurtzke multiple sclerosis rating scale
Item
5. ambulatory with converted kurtzke edss score of 0 - 5.
boolean
C0439841 (UMLS CUI [1,1])
C0451246 (UMLS CUI [1,2])
Condition Neurologic Stable | Relapse Free of
Item
6. relapse free and stable neurological condition at least for 30 days prior screening.
boolean
C0348080 (UMLS CUI [1,1])
C0205494 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0035020 (UMLS CUI [2,1])
C0332296 (UMLS CUI [2,2])
Age
Item
7. age - 18-55 (inclusive)
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Copaxone | glatiramer acetate
Item
1. previous use of copaxone (glatiramer acetate)
boolean
C0528175 (UMLS CUI [1])
C0289884 (UMLS CUI [2])
Adrenal Cortex Hormones
Item
2. treatment with corticosteroids within 30 days prior screening or between screening and baseline.
boolean
C0001617 (UMLS CUI [1])
Adrenal Cortex Hormones chronic
Item
3. chronic corticosteroids treatment - more than 30 consecutive days.
boolean
C0001617 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Medical condition Clinical Significance | Medical condition Unstable
Item
4. subject with any clinically significant or unstable medical condition.
boolean
C3843040 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Study Subject Participation Status
Item
5. subjects participating in any other clinical trial (within 12 weeks prior to screening and thereafter).
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Gadolinium | Magnetic Resonance Imaging Receive Unable
Item
6. known history of sensitivity to gadolinium and inability to successfully undergo mri scanning.
boolean
C0020517 (UMLS CUI [1,1])
C0016911 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial